Schedule 13G ownership disclosure
LANTERN PHARMA INC
Security class unavailable · CUSIP: 51654W101
Event date: 2022-11-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 910,000
- Percent of class
- 8.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-22-033103
- Form type
- SC 13G
- Filer
- Lantern Pharma Inc.
- CIK
- CIK 1763950
- Filed
- Nov 21, 2022
- Reporting period
- Nov 08, 2022
- Description
- Schedule 13G beneficial ownership